<DOC>
	<DOCNO>NCT00296530</DOCNO>
	<brief_summary>This study last 6 week . Subjects visit clinic 5 time . Certain clinic visit include physical examination , medical history review , lung function test . All study relate medication medical examination provide cost subject . The drug use study approve age group study .</brief_summary>
	<brief_title>Study Of Patients With Allergic Rhinitis And Asthma</brief_title>
	<detailed_description>A Multicenter , Randomized , Double-Blind , Triple-Dummy , Placebo-Controlled , Parallel Group , Four-Week Study Assessing Efficacy Fluticasone Propionate Aqueous Nasal Spray 200mcg QD versus Montelukast 10mg QD Adolescent Adult Subjects Asthma Seasonal Allergic Rhinitis Who Receiving ADVAIR DISKUSÂ® 100/50mcg BID Placebo BID</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Have asthma least 3 month prior study . Have use allow prestudy asthma therapy least 3 month prior study . Currently seasonal allergic rhinitis seasonal onset allergic rhinitis least two previous allergy season . Have positive allergy skin test . Have history lifethreatening asthma . Been hospitalize asthma within 6 month prior study . Have certain condition would make study participation unsafe . The study doctor evaluate inclusion exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Allergic Rhinitis</keyword>
</DOC>